The presence of a molecular scaffold to orient a basic group is important for potent and selective κ opioid antagonist selectivity. An attempt to determine how the geometry of the scaffold affects this selectivity has led to the synthesis of a bivalent ligand (5) whose linker constrains the N17′ basic nitrogen (the "address") to a position that is 6.5 Å from N17′ in the κ antagonist norBNI (1) when these molecules are superimposed. The fact that compound 5 was found to be a highly selective and potent μ-selective antagonist supports the idea that the position of N17′ in 5 precludes effective ion pairing with the nonconserved residue Glu297 on outer loop 3 of the κ opioid receptor. The high μ receptor binding affinity and in vitro pharmacological selectivity of 5 coupled with its presumed low central nervous system bioavailability suggest that it may be a useful antagonist for the investigation of peripheral μ opioid receptors.

Bolognesi M., Ojala W.H., Gleason W.B., Griffin J.F., Farouz-Grant F., Larson D.L., et al. (1996). Opioid antagonist activity of naltrexone-derived bivalent ligands: Importance of a properly oriented molecular scaffold to guide "address" recognition at κ opioid receptors. JOURNAL OF MEDICINAL CHEMISTRY, 39(9), 1816-1822 [10.1021/jm950807f].

Opioid antagonist activity of naltrexone-derived bivalent ligands: Importance of a properly oriented molecular scaffold to guide "address" recognition at κ opioid receptors

Bolognesi M.;
1996

Abstract

The presence of a molecular scaffold to orient a basic group is important for potent and selective κ opioid antagonist selectivity. An attempt to determine how the geometry of the scaffold affects this selectivity has led to the synthesis of a bivalent ligand (5) whose linker constrains the N17′ basic nitrogen (the "address") to a position that is 6.5 Å from N17′ in the κ antagonist norBNI (1) when these molecules are superimposed. The fact that compound 5 was found to be a highly selective and potent μ-selective antagonist supports the idea that the position of N17′ in 5 precludes effective ion pairing with the nonconserved residue Glu297 on outer loop 3 of the κ opioid receptor. The high μ receptor binding affinity and in vitro pharmacological selectivity of 5 coupled with its presumed low central nervous system bioavailability suggest that it may be a useful antagonist for the investigation of peripheral μ opioid receptors.
1996
Bolognesi M., Ojala W.H., Gleason W.B., Griffin J.F., Farouz-Grant F., Larson D.L., et al. (1996). Opioid antagonist activity of naltrexone-derived bivalent ligands: Importance of a properly oriented molecular scaffold to guide "address" recognition at κ opioid receptors. JOURNAL OF MEDICINAL CHEMISTRY, 39(9), 1816-1822 [10.1021/jm950807f].
Bolognesi M.; Ojala W.H.; Gleason W.B.; Griffin J.F.; Farouz-Grant F.; Larson D.L.; Takemori A.E.; Portoghese P.S.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/955525
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 18
social impact